Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
Description
invited as CML expert by the International CML Foundation to present highlights of the past Conference of the European Haematology Association, EHA.
Program:
Clinical overview (Rüdiger Hehlmann)
COVID-19 and CML (Rea, Breccia et al., S154)
Personalized management and the new ELN Recommendations for treating CML (Hochhaus, Cortes et al, S153 / Saußele et al, S152)
Monitoring MRD in CML: New developments (Cross)
CML Genomics and the HARMONY PLUS project (Branford)
Biological overview (Ilaria Pagani)
Spotlight talk on Leukaemic stem cells (LSC's) on metabolism (Jones)
Response, resistance and treatment-free remission in CML
Mitochondrial DNA mutations are associated with response to imatinib in chronic myeloid leukemia patients (Pagani, S151)
Loss of G0/G1 switch gene 2 (G0S2) in CML promotes TKI resistance by deregulating the mitochondrial electron transport chain (Gonzalez, S150)
Q&A Session